<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>FOLBIC- pyridoxine, cyanocobalamin and folic acid tablet </strong><br>NCS HealthCare of KY, Inc dba Vangard Labs<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Folbic Tablet</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="LINK_5f2b6928-cb06-42bd-a914-4272e1d2ad4d"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Each rose colored tablet contains the following active ingredients: Folacin (Folic Acid) 2.5 mg, Pyridoxine (B6) 25mg, Cyanocobalamin (B12) 2mg, Folbic Tablets do not contain sugar or lactose.</p>
<p>Inactive Ingredients: Carmine, Croscarmellose Sodium, Dicalcium Phosphate, Hypromellose, Magnesium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Mineral Oil, Riboflavin, Sodium Lauryl Sulfate, Stearic Acid, Titanium Dioxide and Triacetin.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="LINK_1818e800-508b-427b-8eac-de0592150b17"></a><a name="section-2"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Folbic Tablets are indicated for the distrinct nutritional requirements of individuals under a physician's supervision for hyperhomocysteinemia; with particular emphasis for individuals with or at risk for atheroscierotic vascular disease in the coronary, peripheral, or cerebral vessels, or vitamin B12 dificiency.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="LINK_617f5098-9625-4668-83a5-5bfcf544d390"></a><a name="section-3"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components in the product is a contraindication.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="LINK_fda1cbc4-60df-42f5-aeef-a34d8cfa784e"></a><a name="section-4"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">KEEP THIS  AND ALL MEDICATIO OUT OF THE REACH OF CHILDREN IN CASE OF ACCIDENTAL <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">OVERDOSE</span>, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.</p>
<p>All prescription substitutions using this product ahall be pursuant ot state statutes as applicable. This is not an Orange Book Product.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="LINK_531c3306-3f32-439e-a257-bd83bb420bc8"></a><a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="LINK_7dca333a-b746-48db-8c9d-91692f45bba2"></a><a name="section-5.1"></a><p></p>
<h2>General</h2>
<p class="First">Folacin (folic acid) when administered as a single agent in doses above 0.1 mg daily may obscure pemicious <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span> in that hematologic remission can occur while neurological manifestations remain progressive. The 2mgs of cyanocobalamin contained in Folbic Tablets has been shown to provide an adequate amount of cyanocobalamin to address this precaution. Unmetabolized folic acid has been shown in one study of 105 postmenopausal women (50-75 yrs) to have the potential to reduce natural killer cells' cytotoxicity, which may result in an impaired immune response.</p>
<p>Cyanocobalamin should not be used in those with Leber's <span class="product-label-link" type="condition" conceptid="372914" conceptname="Optic atrophy">optic atrophy</span>. Decreased levels of B12 have been associated with reduced ability to detoxify the cyanide in exposed individuals and cyanocobalamin may increase the risk of irreversible neurological damage from <span class="product-label-link" type="condition" conceptid="372914" conceptname="Optic atrophy">optic atrophy</span> in those affected with the disorder. Hydroxocobalamin can aid in the detoxification of cyanide. This form of B12 is an acceptable form for B12 supplementation in those with this disorder.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="LINK_e69a2ad4-3aa5-466c-9aa3-2656a8109ee3"></a><a name="section-5.2"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Pyridoxine supplements should not be given to patients receiving the drug levodopa, because the action of levodopa is antagonized by pyridoxine. However, pyridoxine may be used concurrently in patients recieving a a preparation containing both carbidopa and levodopa. Concurrent use of phenytoin and folacin (folic acid) may result in decreased phenytoin effectiveness.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="LINK_cef0aae2-8a7d-4a3b-b607-300bb3f6f791"></a><a name="section-5.3"></a><p></p>
<h2>Pregnancy</h2>
<p class="First">Pregnant women and nursing mothers should only use 12 microgram doses of B12 (cyanocobalamin) from nutritional supplements. Doses higher than this should only be recommended by your physician. Administration of doses of vitamin B12 greater than 10 micrograms daily may produce a hematological response in those with <span class="product-label-link" type="condition" conceptid="439777" conceptname="Anemia">anemia</span> secondary to <span class="product-label-link" type="condition" conceptid="4101280" conceptname="Folic acid deficiency">folate deficiency</span>.</p>
<p>If pregnant, or planning to become pregnant or are currently breast-feeding please contact your physician, or health-care provider before using or continuing use.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="LINK_0467a44c-c13d-4cfb-90f5-1a9a764e8eed"></a><a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Allergic sensitization has been reported following both oral an dparental administration of folacin (folic acid). <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">Paresthesia</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">somnolence</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span> have been reported with pyridoxine. Mild transient <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, polycythemis vera, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, transitory <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">exanthema</span>, and the feeling of <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> of the entire body has been associated with cyanocobalamin.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="LINK_fc0aae3c-625b-477e-87f9-2c92ac5430e5"></a><a name="section-7"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Usual adult dose is one to two tablets daily or as directed by a physician.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="LINK_e9f0edd2-aad4-4b9e-a185-bbd3c5d7c047"></a><a name="section-8"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Folbic Tablets are available as an oval, rose colored tablet, debossed B 384. Supplied in blisterpacks of 30 tablets, NDC# 0615-7575-39.</p>
<p>Store at 25 degrees C (77 degrees F); excursions permitted to 15 degrees - 30 degrees C (59 degrees - 86 degrees F). See USP Controlled Room Temperature. Protect from light and moisture.</p>
<p>Dispense in a tight, light resistant container with a child-resistant closure as defined in the USP/NF.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="LINK_c210015c-cc88-440f-b65c-867c8c820707"></a><a name="section-9"></a><p></p>
<h1>REFERENCES</h1>
<p class="First">Rx Only</p>
<p>Manufacitred by: Contract Pharmacal Corp. Hauppauge, NY 11788</p>
<p>Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487</p>
<p>Some or all of the following patents may apply: U.S Patent No. 4,940,658, U.S. Patent No. 5,563,126, U.S. Patent No. 5,795,873, U.S. Patent No. 6,207,651, U.S. Patent No. 6,297,224, U.S. Patent No. 6,528,496 and other pending patent applications.</p>
<p>References:</p>
<p>Elkelboom JW, Lonn Eva, Genest Jr Jaques, Hankey Graeme, Yusuf Salim: Homocysteine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence. Ann Intern Med. 1999; 131:363-375.</p>
<p>The Homocysteine Studies Collaboration: Homocysteine and Risk of  <span class="product-label-link" type="condition" conceptid="4124683" conceptname="Silent myocardial ischemia">Ischemic Heart Disease</span> and <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">Stroke</span>, JAMA 2002; Vol 288, No 16:2015-2002.</p>
<p>Refusum Helga, Smith A. David: Ueland Per M. Nexo Ebba, Clarke Robert, McPartlin Joseph, Johnston Carole, Engbaek Frode, Schneede Jorn, McPartlin Catherine, and Scott John M: Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion. Clinical Chemisty 2004; 50:1 3-32.</p>
<p>Kuzminski AM, Del Giacco EJ, Aften RH, et ai: Effective Treatment of Cobalamin Defiiency with oral Cobalamin. Blood 1998; 92:1191-1198.</p>
<p>Troen AM, Mitchell B. Sorensen B. Wener MH, Hohnston A, Wood B. Selhub J. McTiernan A, Yasui Y, Oral E, Potter JD, and Ulrich CM, Unmetabolized Folic Acid in Plasma ia Associated with Reduced Natural Killer Cell Cytotoxicity among Postmenopausal Women. Jounal of Nutrition 2006 Jan; 136 (1): 189-194.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="LINK_0e6210b7-ab96-4eb9-9aee-3aa078f9c47b"></a><a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL</h1>
<p class="First">Folbic Tabs 2.5mg/25mg/2mg</p>
<div class="Figure"><img alt="Principal Display Panel - Folbic Tablets 2.5mg/25mg/2mg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=99121923-2b2d-427a-865a-e8b7dd052569&amp;name=folbic-tablet-1.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>FOLBIC 		
					</strong><br><span class="contentTableReg">pyridoxine and cyanocobalamin and folic acid tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0615-7575(NDC:51991-384)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>PYRIDOXINE</strong> (PYRIDOXINE) </td>
<td class="formItem">PYRIDOXINE</td>
<td class="formItem">25 mg</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>CYANOCOBALAMIN</strong> (CYANOCOBALAMIN) </td>
<td class="formItem">CYANOCOBALAMIN</td>
<td class="formItem">2 mg</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>FOLIC ACID</strong> (FOLIC ACID) </td>
<td class="formItem">FOLIC ACID</td>
<td class="formItem">2.5 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CARMINIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CROSCARMELLOSE SODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS DIBASIC CALCIUM PHOSPHATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYPROMELLOSES</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM SILICATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CELLULOSE, MICROCRYSTALLINE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MINERAL OIL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>RIBOFLAVIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TRIACETIN</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">PINK (Rose) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">OVAL</td>
<td class="formLabel">Size</td>
<td class="formItem">11mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">B;384</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0615-7575-39</td>
<td class="formItem">30  in 1 <span class="product-label-link" type="condition" conceptid="443720" conceptname="Blister">BLISTER</span> PACK</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">UNAPPROVED DRUG OTHER</td>
<td class="formItem"></td>
<td class="formItem">02/19/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>NCS HealthCare of KY, Inc dba Vangard Labs
							(050052943)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NCS HealthCare of KY, Inc dba Vangard Labs</td>
<td class="formItem"></td>
<td class="formItem">050052943</td>
<td class="formItem">RELABEL, REPACK</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 9/2010<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>3e34809d-5f18-4445-b885-e1cea1c6e322</div>
<div>Set id: 99121923-2b2d-427a-865a-e8b7dd052569</div>
<div>Version: 6</div>
<div>Effective Time: 20100923</div>
</div>
</div> <div class="DistributorName">NCS HealthCare of KY, Inc dba Vangard Labs</div></p>
</body></html>
